Gilenya hits 10,000

Quote

Anonymous

Guest
Should we be worried I really thought this drug would be a bust.


Novartis AG (NOVN)’s Gilenya multiple sclerosis pill is “doing very well” in the U.S., with more than 10,000 patients using the treatment, the Swiss drugmaker’s head of development said.
Novartis has been “very diligent” in tracking down side effects and has found the compound’s safety profile to be consistent with the Basel-based drugmaker’s data, Trevor Mundel, the development chief, said today in a phone interview.
 


















Anonymous said:
AS I SAID BEFORE, NOVARTIS COULDN'T LAUNCH A PRODUCT IF THEIR LIFE DEPENDED ON IT.WAIT UNTIL PRIMARY GETS THE DRUG AND A REP IS IN THESE OFFICES EVERYDAY. AND THEY START PISSING EVERYBODY OFF. THEY DID IT WITH RECLAST THEY'LL DO IT WITH GILENYA WAIT AND SEE.
Click to expand...

I agree but at this pace they do have a billion dollar drug. The Biogen reps that left must regret that decision every day.
 












Anonymous said:
I think you are confusing this with Tysabri
Click to expand...


As an MS patient, I think he's absolutely correct in that 'nasty things will happen' with Gilenya, just as they have with Tysabri and just as I also expect they will with Campath.

Although I wouldn't touch any of these MABs drugs with a bargepole, as far as Tysabri is concerned, Biogen has actually started to be somewhat more honest on Tysabri.com about the risks of PML.

It still amazes me that despite the information being out there, sales of Tysabri are increasing. If people choose to take the risks given that the information is out there for everyone to see on Tysabri.com, then that's a choice they have made.

For those who choose to try Gilenya or Campath, with full knowledge that they they bear similar risks to Tysabri, all I can say is good luck to them.

<shrug>
 






Anonymous said:
AS I SAID BEFORE, NOVARTIS COULDN'T LAUNCH A PRODUCT IF THEIR LIFE DEPENDED ON IT.WAIT UNTIL PRIMARY GETS THE DRUG AND A REP IS IN THESE OFFICES EVERYDAY. AND THEY START PISSING EVERYBODY OFF. THEY DID IT WITH RECLAST THEY'LL DO IT WITH GILENYA WAIT AND SEE.
Click to expand...


Clearly whatever company you work for doesn't provide a company caps lock off bonus.
 






I've been paying my co-pay for Gilenya since January. Since then I have had no incidents or issues with the drug at all. It is working as well as the other two injectible drugs I have taken in the past and without the stress of giving myself the injections.
 






Top Bottom
Back
Quote